Arcturus Therapeutics Holdings Inc. (ARCT)

ARCT Ratios and Metrics

Market cap in millions USD. Fiscal year is January - December.

Fiscal Year	Current	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	May 14, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020
Market Capitalization	316	460	843	450	976	1,122
Market Cap Growth	-68.40%	-45.45%	87.08%	-53.84%	-13.03%	581.69%
Enterprise Value	147	252	582	307	629	835
Last Close Price	11.86	16.97	31.53	16.96	37.01	43.38
PE Ratio	-	-	-	48.17	-	-
PS Ratio	2.23	3.02	5.05	2.19	78.94	117.59
PB Ratio	1.38	1.91	3.03	1.67	4.28	2.83
P/TBV Ratio	1.38	1.91	3.03	1.67	4.28	2.83
P/FCF Ratio	-	-	-	18.56	-	-
P/OCF Ratio	-	-	-	14.08	-	-
EV/Sales Ratio	1.03	1.65	3.49	1.49	50.89	87.55
EV/EBITDA Ratio	-	-	-	22.44	-	-
EV/EBIT Ratio	-	-	-	25.25	-	-
EV/FCF Ratio	-	-	-	12.67	-	-
Debt / Equity Ratio	0.18	0.12	0.11	0.35	0.30	0.05
Debt / EBITDA Ratio	-	-	-	5.15	-	-
Debt / FCF Ratio	-	-	-	3.91	-	-
Asset Turnover	0.38	0.39	0.38	0.49	0.03	0.03
Quick Ratio	4.69	3.68	3.95	3.11	3.76	9.39
Current Ratio	5.64	4.67	4.72	3.18	3.81	9.45
Return on Equity (ROE)	-27.40%	-31.16%	-10.83%	3.75%	-65.20%	-34.16%
Return on Assets (ROA)	-13.67%	-15.46%	-11.11%	1.80%	-29.17%	-16.00%
Return on Capital (ROIC)	-17.93%	-20.68%	-14.51%	2.30%	-35.48%	-19.28%
Return on Capital Employed (ROCE)	-	-	-	3.80%	-	-
Earnings Yield	-21.20%	-17.61%	-3.53%	2.08%	-20.88%	-6.43%
FCF Yield	-27.94%	-13.14%	-2.49%	5.39%	-14.19%	-3.98%
Buyback Yield / Dilution	-1.30%	-1.40%	1.72%	-2.95%	-29.61%	-68.24%

Updated May 12, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.

SEC Filings: 10-K · 10-Q